Evidence map›Paper›PMID 37373497›Full record

ArticleInternational journal of molecular sciences2023

Differential Lipidomics, Metabolomics and Immunological Analysis of Alcoholic and Non-Alcoholic Steatohepatitis in Mice.

Erika Dorochow, Nico Kraus, Nicolas Chenaux-Repond, Sandra Pierre, Anja Kolbinger, Gerd Geisslinger, Cristina Ortiz, Christoph Welsch, Jonel Trebicka, Robert Gurke and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Wanted: Dead or Alive Cells with Propidium Iodide Staining in Liver Tissue.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Erika DorochowInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0002-0383-3273
Nico KrausCenter for Internal Medicine, Hospital of the Goethe University Frankfurt, 60323 Frankfurt, Germany.ORCID 0000-0002-5162-1048
Nicolas Chenaux-RepondInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.ORCID 0009-0002-4967-2791
Sandra PierreInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
Anja KolbingerInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0003-3120-7277
Gerd GeisslingerInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
Cristina OrtizCenter for Internal Medicine, Hospital of the Goethe University Frankfurt, 60323 Frankfurt, Germany.
Christoph WelschCenter for Internal Medicine, Hospital of the Goethe University Frankfurt, 60323 Frankfurt, Germany.ORCID 0000-0002-1823-4863
Jonel TrebickaClinic for Internal Medicine B, Hospital of the University of Münster, 48149 Münster, Germany.
Robert GurkeInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0001-8218-1295
Lisa HahnefeldInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.ORCID 0000-0002-0382-5695
Sabine KleinClinic for Internal Medicine B, Hospital of the University of Münster, 48149 Münster, Germany.
Klaus ScholichInstitute of Clinical Pharmacology, Goethe-University Frankfurt, 60590 Frankfurt, Germany.
Goethe University Frankfurt · DEUniversity of Münster · DE

Funding

Deutsche Forschungsgemeinschaft 445757098Deutsche Forschungsgemeinschaft CPI EXC 2026, Project ID: 390649896Deutsche Forschungsgemeinschaft GRK2336 (TP07)Deutsche Forschungsgemeinschaft SCHO817/3-3Deutsche Forschungsgemeinschaft SFB1039 (TP A08)Fraunhofer Cluster of Excellence for Immune-Mediated Diseases CMIDLOEWE Centre ACLF-I P02, Z01
6 · The paper itself

Abstract

Non-alcoholic steatohepatitis (NASH) and alcoholic steatohepatitis (ASH) are the leading causes of liver disease worldwide. To identify disease-specific pathomechanisms, we analyzed the lipidome, metabolome and immune cell recruitment in livers in both diseases. Mice harboring ASH or NASH had comparable disease severities regarding mortality rate, neurological behavior, expression of fibrosis marker and albumin levels. Lipid droplet size was higher in NASH than ASH and qualitative differences in the lipidome were mainly based on incorporation of diet-specific fatty acids into triglycerides, phosphatidylcholines and lysophosphatidylcholines. Metabolomic analysis showed downregulated nucleoside levels in both models. Here, the corresponding uremic metabolites were only upregulated in NASH suggesting stronger cellular senescence, which was supported by lower antioxidant levels in NASH as compared to ASH. While altered urea cycle metabolites suggest increased nitric oxide synthesis in both models, in ASH, this depended on increased L-homoarginine levels indicating a cardiovascular response mechanism. Interestingly, only in NASH were the levels of tryptophan and its anti-inflammatory metabolite kynurenine upregulated. Fittingly, high-content immunohistochemistry showed a decreased macrophage recruitment and an increased polarization towards M2-like macrophages in NASH. In conclusion, with comparable disease severity in both models, higher lipid storage, oxidative stress and tryptophan/kynurenine levels were seen in NASH, leading to distinct immune responses.

Indexed as

Non-alcoholic Fatty Liver DiseaseAnimalsDisease Models, AnimalFatty AcidsKynurenineLipidomicsLiverMetabolomicsMiceTryptophanFatty AcidsKynurenineTryptophanalcoholic fatty liver diseaselipid dropletslipidomicsmetabolomicsnon-alcoholic fatty liver disease

Identifiers

PMID37373497
PMCPMC10299521
OpenAlexW4381429396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.